ARTICLE | Company News
GeneProt, Lundbeck CNS proteomics deal
April 22, 2004 7:00 AM UTC
GeneProt (Geneva, Switzerland) will use its MicroProt process to study the proteomics of fluid samples taken from a rodent model of CNS disease. Lundbeck (CSE:LUN) will have exclusive rights to commer...